Genelux Stock (NASDAQ: GNLX) stock price, news, charts, stock research, profile.
Open | $1.82 |
Close | $1.71 |
Volume / Avg. | 206.30K / 263.88K |
Day Range | 1.71 - 1.87 |
52 Wk Range | 1.84 - 35.15 |
Market Cap | $58.74M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 29 |
Short Interest | 5.84% |
Days to Cover | 9.68 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Genelux (NASDAQ:GNLX) through any online brokerage.
Other companies in Genelux’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Intensity Therapeutics (NASDAQ:INTS), CARISMA Therapeutics (NASDAQ:CARM), Burning Rock Biotech (NASDAQ:BNR) and Barinthus Biotherapeutics (NASDAQ:BRNS).
There is no analysis for Genelux.
Genelux has a consensus price target of $30.50.
The stock price for Genelux (NASDAQ: GNLX) is $1.71 last updated Today at July 2, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Genelux.
Genelux’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Genelux.
Genelux is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.